Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting

OBJECTIVE: To assess the cost effectiveness of once weekly rifapentine and isoniazid for 12 weeks (3HP) to the current standard care for latent tuberculosis (TB) infection (LTBI) in Iqaluit, Nunavut. DESIGN: A cost-effectiveness analysis using a Markov model reflecting local practices for LTBI treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pease, Christopher, Alvarez, Gonzalo, Mallick, Ranjeeta, Patterson, Mike, Finn, Sandy, Habis, Yahya, Schwartzman, Kevin, Kilabuk, Elaine, Mulpuru, Sunita, Zwerling, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126298/
https://www.ncbi.nlm.nih.gov/pubmed/33986067
http://dx.doi.org/10.1136/bmjopen-2020-047514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126298/
https://www.ncbi.nlm.nih.gov/pubmed/33986067
http://dx.doi.org/10.1136/bmjopen-2020-047514

Ejemplares similares